<DOC>
	<DOCNO>NCT01740817</DOCNO>
	<brief_summary>The purpose study determine whether lipid infusion up-regulate toll-like receptor 4 ( TLR4 ) signal human subject</brief_summary>
	<brief_title>A Study Evaluate Effect Lipid Infusion Toll Like Receptor 4 ( TLR4 ) Signaling</brief_title>
	<detailed_description>The investigator plan examine effect lipid infusion TLR4 expression insulin sensitivity . A group 30 subject age 18-60 year old , lean ( BMI &lt; 26 kg/m2 ) normal glucose tolerant subject without family history type 2 diabetes receive lipid saline infusion . The subject randomly assign first receive either 48 hour long lipid saline infusion . Approximately 4-6 week later subject return undergo another study ( , first study receive lipid , second study receive saline , vice versa ) . A near-equal number woman men include group .</detailed_description>
	<mesh_term>Soybean oil , phospholipid emulsion</mesh_term>
	<criteria>1 . Subjects must follow laboratory value : Hematocrit ≥ 35 % , serum creatinine ≤ 1.5 mg/dl , aspartate aminotransferase ( AST ) &lt; 2 X upper limit normal , Alanine aminotransferase ( ALT ) &lt; 2 X upper limit normal , alkaline phosphatase &lt; 2 X upper limit normal , normal urinalysis [ glucose , trace protein , trace ketone , lipase &lt; 50 IU/L , bacteria , 13 white blood cell ( WBC ) red blood cell ( RBC ) per hpf ] , normal platelet , prothrombin time ( PT ) partial thromboplastin time ( PTT ) . 2 . Female subject must nonlactating . Female patient eligible negative pregnancy test throughout study period ( postmenopausal ) . Postmenopausal woman take hormone replacement include stable dose ≥6 month . 3 . Subjects whose body weight stable ( within 2 % ) least three month . 1 . Subjects impair glucose tolerance base American Diabetes Association criterion . 2 . Subjects take drug know affect glucose lipid homeostasis exclude . Statins permit subject stable dose least three month . Subjects take week nonsteroidal anti inflammatory drug ( NSAIDS ) within two month systemic steroid , anabolic steroid , growth hormone immunosuppressant within 12 month exclude . Subjects take lowdose ( 81 mg/day less ) aspirin allow . 3 . Patients history clinically significant heart disease ( New York Heart Classification great grade II ; nonspecific STT wave change EKG ) , peripheral vascular disease ( history claudication ) , pulmonary disease ( dyspnea exertion one flight le ; abnormal breath sound auscultation ) study . 4 . Recent systemic pulmonary embolus , impaired renal function , poorly control blood pressure ( systolic BP &gt; 170 , diastolic BP &gt; 95 ) , rest heart rate &gt; 100 , electrolyte abnormality , neuromuscular musculoskeletal disease . 5 . Subjects smoke . 6 . Subjects engage regular exercise program ( zero one exercise session per week allow ) . 7 . Any subject donate blood previous two month . 8 . Any subject hematocrit le 35 . 9 . Subjects claustrophobic . 10 . Women take oral contraceptive . 11. alcohol consumption great 30 gram daily . 12. baseline plasma triglyceride level 200 mg/dl</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>diabetes</keyword>
	<keyword>obesity</keyword>
	<keyword>inflammation</keyword>
</DOC>